Faculty of Medicine
Permanent URI for this communityhttps://repository.ukim.mk/handle/20.500.12188/14
Browse
15 results
Search Results
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, METABOLIC SYNDROME IN ANTIRETROVIRAL THERAPY TREATMENT EXPERIENCED BY PEOPLE LIVING WITH HIV(Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, 2024); ; ; ;Saveski, VelimirIntroduction: Metabolic syndrome (MS) constitutes a group of risk factors that significantly affect the quality of life and life expectancy of people living with HIV. Aim: To estimate the prevalence of MS among people living with HIV who receive antiretroviral therapy (ART) in the Republic of North Macedonia (RNM). Material and methods: A study was conducted on 53 adult patients with confirmed HIV infection at the University Clinic for Infectious Diseases and Febrile Conditions, who are receiving ART. In all patients, the presence of MS was determined according to the criteria of the National Cholesterol Education Program Adult Treatment Panel ATP III (NCEP ATP III), defined by at least three of five risk factors including: low values of HDL - high density lipoprotein cholesterol, elevated waist circumference, hypertriglyceridemia, increased values of fasting glucose and hypertension. The statistical analysis was made by utilizing the statistical program SPSS 23.0. Results: The average age of patients was 35.7 ± 8.3, with a male predominance of 90.57%. All patients had undetectable values of HIV RNA viral load in serum and 79.25% had achieved immune reconstitution with a CD4 count above 350 cells/ml. The prevalence of MS among people living with HIV in RNM was 7.55%, or out of 53 respondents 4 had MS. Conclusion: People with HIV infection in RNM who regularly receive ART have a low prevalence of metabolic syndrome. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, SAFETY AND EFFECTIVENESS OF DIRECT-ACTING ANTIVIRALS IN PATIENTS WITH CHRONIC HEPATITIS C AND CHRONIC KIDNEY DISEASE(Macedonian Infectious Diseases Society, 2022-11); ; ;Gasheva, Magdalena; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Clinical experience in the treatment of flu patients with Oseltamivir during the interpandemic period(National Center of Infectious and Parasitic Diseases, 2002-11) ;Markovski, Velo; ; Toshevski, Boban - Some of the metrics are blocked by yourconsent settings
Item type:Publication, EFFICACY AND SAFETY OF THE NEURAMINIDASE INHIBITOR OSELTAMIVIR IN THE TREATMENT OF INFLUENZA INFECTIONS IN ADULTS(2002-10) ;Markovski, Velo; ;Toshevski, Boban - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Seroprevalence of HBV markers in medical students(Clinical Microbiology and Infection, 2004-05) ;Toshevski, Boban ;Ivanovski, Ljubomir ;Dimitriev, Dimitar ;Gasheva, MagdalenaGrunevska, Violeta - Some of the metrics are blocked by yourconsent settings
Item type:Publication, THE BEGINNING OF THE NEW ERA IN THE TREATMENT OF HCV INFECTION(Macedonian Medical Association, Macedonian Infectious Diseases Society, 2016-10) ;Gasheva, Magdalena ;Evtimovska, Cvetanka ;Toshevski, Boban; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Etiological aspects of chronic viral hepatitis(International Society for Infectious Diseases, 2004-03) ;Evtimovska,Cvetanka ;Dimitriev, Dimitar ;Gasheva, Magdalena ;Ivanovska, JulijanaGrunevska, Violeta - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Motivation of health care workers for Hepatitis B vaccination(International Society for Infectious Diseases, 2004-03) ;Gasheva, Magdalena ;Ivanovski, Ljubomir ;Dimitriev, Dimitar ;Evtimovska, CvetankaGrunevska, Violeta - Some of the metrics are blocked by yourconsent settings
Item type:Publication, HCV genotype prevalence among HCV infected i.v drug users in the Republic of Macedonia in 2004 and 2006(International Society for Infectious Diseases, 2006-06) ;Grunevska, Violeta ;Ivanovski, Ljubomir ;Dimitriev, Dimitar ;Nastevska, CvetankaGasheva, Magdalena - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Prediction of Early Virological Response-4 versus 12 weeks of Peginterferon alfa2a (40KD) plus Ribavirin Treatment in Chronic Hepatitis C patients(International Society for Infectious Diseases, 2006-06) ;Gasheva, Magdalena ;Ivanovski, Ljubomir ;Evtimovska, Cvetanka ;Grunevska, Violeta
